drugset / Trial / NCT00760955
Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and effectiveness of TAK-583, once daily (QD), in the treatment of neuropathy caused by diabetes mellitus.
Timeline
- Start
- 2006-09
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-583 | Unknown | 5 mg | Oral |
| Subject | TAK-583 | Unknown | 50 mg | Oral |
| Subject | TAK-583 | Unknown | 100 mg | Oral |